O-GlcNAcylation protein disruption by Thiamet G promotes modifications on the GBM U87-MG cells secretome molecular signature   Glioblastoma (GBM) is a grade IV glioma extremely aggressive and refractory to the therapeutic approaches presently in use. O-GlcNAcylation performs a key position for tumor aggressiveness and development in various kinds of most cancers; nevertheless, experimental proof of its involvement […]